— Know what they know.
Not Investment Advice
Also trades as: 4967.T (JPX) · $vol 12M

KBYPF OTC

Kobayashi Pharmaceutical Co., Ltd.
1W: +15.9% 1M: +15.9% 3M: +15.9% YTD: +14.0% 1Y: +5.5% 3Y: -26.9% 5Y: -51.5%
$39.47
+0.00 (+0.00%)
 
OTC · Consumer Defensive · Household & Personal Products · Tech Score Buy · Power 73 · $2.9B mcap · 48M float · 0.0026% daily turnover · Short 87% of daily vol

Income Trends

Revenue
$165.9B +0.2% ▲
5Y CAGR: +2.0%
Gross Profit
$79.5B -9.2% ▼
5Y CAGR: -1.4%
Operating Income
$14.9B -40.2% ▼
5Y CAGR: -10.5%
Net Income
$3.7B -63.7% ▼
5Y CAGR: -28.2%
EPS (Diluted)
$48.62 -64.1% ▼
5Y CAGR: -27.7%
EBITDA
$23.6B +7.5% ▲
5Y CAGR: -4.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$155.3B$166.3B$173.5B$165.6B$165.9B
YoY Growth+3.1%+7.1%+4.3%-4.5%+0.2%
Cost of Revenue$66.5B$73.9B$77.1B$78.0B$86.4B
Gross Profit$88.8B$92.3B$96.4B$87.6B$79.5B
Gross Margin57.2%55.5%55.6%52.9%47.9%
R&D Expenses$7.5B$8.3B$9.0B$9.1B$9.1B
SG&A Expenses$31.8B$31.6B$57.6B$22.0B$54.3B
Operating Expenses$62.7B$65.7B$70.6B$62.7B$64.6B
Operating Income$26.1B$26.7B$25.8B$24.9B$14.9B
Operating Margin16.8%16.0%14.9%15.0%9.0%
Interest Expense$18M$18M$29M$28M$28M
Income Before Tax$27.6B$27.9B$27.6B$13.9B$3.7B
Tax Expense$7.9B$7.9B$7.2B$3.8B$83M
Net Income$19.7B$20.0B$20.3B$10.1B$3.7B
Net Margin12.7%12.0%11.7%6.1%2.2%
EPS (Diluted)$252.36$259.59$268.16$135.42$48.62
EBITDA$30.8B$31.9B$33.6B$22.0B$23.6B
Shares Outstanding78M77M76M74M74M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms